Icon

EFFIENT (nda022307)- (EQ 5MG BASE,EQ 10MG BASE)

PRASUGREL HYDROCHLORIDE COSETTE
EQ 5MG BASE,EQ 10MG BASE
Yes No
2023-Jul-02 2014-Jul-10
None None
None No
Effient is a P2Y12 platelet inhibitor indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with percutaneous coronary intervention (PCI) as follows:  Patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI).  Patients with ST-elevation myocardial infarction (STEMI) when managed with either primary or delayed PCI
9 0 6
Total Other Developers 5
Drugs with Suitability No
EQ 5MG BASE ** ** - 5 -
EQ 10MG BASE ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ******* ******* ****** ****** ******* *********** ******, *****, *****, ******** ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ****** ****** ****** *************** ******* ******* *********** ***/*-***, ******* ****** **** ***** *********, *****, *********, ******, ***** (***) ***
****** ******* ******* ************ ******* *********** **** **. ** ** **, ******* ********** ******, *******, ******, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.